Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors
申请人:Taniguchi Takahiko
公开号:US09150588B2
公开(公告)日:2015-10-06
A compound having PDE inhibitory represented by formula (1), W1-W2 (1), wherein (i) W1 is
and W2 is
(ii) W1 is
and W2 is
or (iii) W1 is
and W2 is
or a pharmaceutically acceptable salt thereof; and a method of treating or preventing schizophrenia.